EUVIMEDEUVIMED entdecken
Crossref

Catastrophic Antiphospholipid Syndrome

Jean-Christophe Gris iD, Mathias Chea iD, Antonia Perez-Martin iD

Seminars in Thrombosis and Hemostasis · 28.01.2026

DOI: 10.1055/a-2765-9663 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Seminars in Thrombosis and Hemostasis, online erschienen am 28.01.2026. Verfasst von Jean-Christophe Gris und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, CHU Nîmes, Univ Montpellier, Nîmes, France. Die Arbeit nennt 70 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Catastrophic antiphospholipid syndrome (CAPS) is a rare, potentially lethal, multiple-faceted, systemic disease, often triggered by a precipitating factor. Its tissue lesions are mainly the consequence of an antiphospholipid antibody (aPL Abs)-mediated thrombotic microangiopathy associated with a so-called cytokine storm. Bleeding may coexist, making it difficult to manage. In an emergency situation, the differential diagnosis is not always straightforward in patients not known to be aPL Abs carriers, or with no history of thrombotic or obstetric complications. What we have gradually learned about its clinical presentation and therapeutic management mainly comes from the CAPS registry. So far, there have been no randomized controlled trials to guide treatment. The current therapeutic recommendations insist on prescribing first-line triple therapy, combining early anticoagulation, immunosuppression, and the removal/neutralization of aPL Abs, as early as possible. The prognosis has improved but remains bleak. Future research to develop pathophysiological treatments blocking the activation of target cells by aPL Abs is warranted.

Autor:innen und Institutionen

  • Department of Haematology, CHU Nîmes, Univ Montpellier, Nîmes, France.
  • UMR 1318 INSERM-INRIA-Université de Montpellier IDESP, Montpellier University, Montpellier, France.
  • Department of Obstetrics, Gynaecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
  • Department of vascular Medicine, CHU Nîmes, Univ Montpellier, Nîmes, France.

ORCID-Profile: Jean-Christophe Gris, Mathias Chea, Antonia Perez-Martin

Zitieren

APA

Gris, J. C., Chea, M., & Perez-Martin, A. (2026). Catastrophic Antiphospholipid Syndrome. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/a-2765-9663

Vancouver

Gris JC, Chea M, Perez-Martin A. Catastrophic Antiphospholipid Syndrome. Seminars in Thrombosis and Hemostasis. 2026. doi:10.1055/a-2765-9663

BibTeX
@article{Gris2026,
  author = {Gris, Jean-Christophe and Chea, Mathias and Perez-Martin, Antonia},
  title = {Catastrophic Antiphospholipid Syndrome},
  journal = {Seminars in Thrombosis and Hemostasis},
  year = {2026},
  doi = {10.1055/a-2765-9663}
}
Kostenlos starten →